Notice of Extra General Meeting in Acarix AB
The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are hereby invited to the extra general meeting to be held on Fri...
Kallelse till extra bolagsstämma i Acarix AB
Aktieägarna i Acarix AB, org.nr 559009-0667, ("Bolaget") kallas härmed till extra bolagsstämma fredagen den 9 juni 2023 ...
Acarix raises approximately SEK 22 million through exercise of warrants and resolves on a directed share issue
In December 2022, Acarix AB (publ) (“Acarix” or the “Company”) carried out a rights issue of shares and warrant...
Acarix tillförs cirka 22 MSEK genom utnyttjandet av teckningsoptioner och beslutar om riktad nyemission
Acarix AB (publ) (“Acarix” eller “Bolaget”) genomförde under december 2022 en företrädesemission...
State-of-the-Art Cardiology Clinic enhances patient care with CADScor System
Acarix, a leader in acoustic and AI-based cardiac diagnostics, announces today that Abo-Auda Associates Cardiologists in Texoma, Texas ...
State-of-the-Art kardiologiklinik förbättrar patientvården med CADScor System
Acarix, ledande inom akustisk och AI-baserad hjärtdiagnostik, meddelar idag att Abo-Auda Associates Cardiologists i Texoma, Texas ...
Acarix Awarded Business Sweden 2023 Catalyst Program Award
Acarix, a leader in acoustic and AI-based cardiac diagnostics, is pleased to announce they have been awarded the 2023 Catalyst Program ...
Acarix tilldelas Business Sweden 2023 Catalyst Program Award
Acarix, ledande inom akustisk och AI-baserad hjärtdiagnostik, har nöjet att meddela tilldelningen av 2023 Catalyst Program Aw...
Announcement from Acarix’s annual general meeting
The annual general meeting 2023 ("AGM") of Acarix AB ("Acarix" or the "Company") was held today on 11 May 2023 in Stockholm and the fol...
Kommuniké från årsstämman i Acarix
Årsstämman 2023 i Acarix AB ("Acarix" eller "Bolaget") hölls idag den 11 maj 2023 i Stockholm varvid aktieägarna f...
Acarix AB (publ) publishes Interim Report, January – March 2023
2023 is off to a good startIn the first quarter of 2023 our strategy delivered important results with a breakthrough order from the lar...
Acarix AB (publ) publicerar delårsrapport, januari – mars 2023
2023 har börjat braUnder första kvartalet 2023 levererade vi viktiga delresultat med en genombrottsorder från den st&ou...